Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.

Fox MP, Cutsem GV, Giddy J, Maskew M, Keiser O, Prozesky H, Wood R, Hernán MA, Sterne JA, Egger M, Boulle A; IeDEA-SA collaboration.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):428-37. doi: 10.1097/QAI.0b013e3182557785.

2.

Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP.

PLoS One. 2016 Aug 22;11(8):e0161469. doi: 10.1371/journal.pone.0161469. eCollection 2016.

3.

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.

Onoya D, Nattey C, Budgell E, van den Berg L, Maskew M, Evans D, Hirasen K, Long LC, Fox MP.

AIDS Patient Care STDS. 2017 May;31(5):205-212. doi: 10.1089/apc.2016.0291. Epub 2017 Apr 26.

4.

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.

Ssempijja V, Nakigozi G, Chang L, Gray R, Wawer M, Ndyanabo A, Kasule J, Serwadda D, Castelnuovo B, Hoog AV, Reynolds SJ.

BMC Infect Dis. 2017 Aug 22;17(1):582. doi: 10.1186/s12879-017-2680-6.

5.

Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.

Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M; IeDEA southern Africa, east Africa, and west Africa.

Lancet HIV. 2015 Jul;2(7):e271-8. doi: 10.1016/S2352-3018(15)00087-9. Epub 2015 Jun 16.

6.

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

ART-LINC of IeDEA Study Group, Keiser O, Tweya H, Boulle A, Braitstein P, Schecter M, Brinkhof MW, Dabis F, Tuboi S, Sprinz E, Pujades-Rodriguez M, Calmy A, Kumarasamy N, Nash D, Jahn A, MacPhail P, Lüthy R, Wood R, Egger M.

AIDS. 2009 Sep 10;23(14):1867-74. doi: 10.1097/QAD.0b013e32832e05b2.

7.

Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa.

Petersen ML, Tran L, Geng EH, Reynolds SJ, Kambugu A, Wood R, Bangsberg DR, Yiannoutsos CT, Deeks SG, Martin JN.

AIDS. 2014 Sep 10;28(14):2097-107.

8.

Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.

De Luca A, Marazzi MC, Mancinelli S, Ceffa S, Altan AM, Buonomo E, Prosperi MC, Pedruzzi B, Noorjehan AM, Scarcella P, Liotta G, Palombi L.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):236-44. doi: 10.1097/QAI.0b013e31824276e9.

PMID:
22327246
9.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
10.

Second-line antiretroviral therapy: long-term outcomes in South Africa.

Murphy RA, Sunpath H, Castilla C, Ebrahim S, Court R, Nguyen H, Kuritzkes D, Marconi VC, Nachega JB.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):158-163. doi: 10.1097/QAI.0b013e3182615ad1.

11.

Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.

Davies MA, Moultrie H, Eley B, Rabie H, Van Cutsem G, Giddy J, Wood R, Technau K, Keiser O, Egger M, Boulle A; International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):270-8. doi: 10.1097/QAI.0b013e3182060610.

12.

Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.

Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D.

Trop Med Int Health. 2016 Sep;21(9):1131-7. doi: 10.1111/tmi.12741. Epub 2016 Jul 7.

13.

Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa.

Shearer K, Evans D, Moyo F, Rohr JK, Berhanu R, Van Den Berg L, Long L, Sanne I, Fox MP.

Trop Med Int Health. 2017 Feb;22(2):221-231. doi: 10.1111/tmi.12804. Epub 2016 Nov 24.

14.

Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.

Johnston V, Cohen K, Wiesner L, Morris L, Ledwaba J, Fielding KL, Charalambous S, Churchyard G, Phillips A, Grant AD.

J Infect Dis. 2014 Mar 1;209(5):711-20. doi: 10.1093/infdis/jit411. Epub 2013 Aug 13.

15.

Outcomes after virologic failure of first-line ART in South Africa.

Murphy RA, Sunpath H, Lu Z, Chelin N, Losina E, Gordon M, Ross D, Ewusi AD, Matthews LT, Kuritzkes DR, Marconi VC; South Africa Resistance Cohort Study Team.

AIDS. 2010 Apr 24;24(7):1007-12. doi: 10.1097/QAD.0b013e3283333639.

16.
17.

Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study.

Childs T, Shingadia D, Goodall R, Doerholt K, Lyall H, Duong T, Judd A, Gibb DM, Collins IJ; CHIPS Steering Committee.

Lancet HIV. 2015 Apr;2(4):e151-8.

18.

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.

Schoffelen AF, Wensing AM, Tempelman HA, Geelen SP, Hoepelman AI, Barth RE.

PLoS One. 2013;8(3):e58526. doi: 10.1371/journal.pone.0058526. Epub 2013 Mar 11.

19.

Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.

Rewari BB, Bachani D, Rajasekaran S, Deshpande A, Chan PL, Srikantiah P.

J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):610-4. doi: 10.1097/QAI.0b013e3181f43a31.

PMID:
20890211
20.

Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.

Jourdain G, Le Cœur S, Ngo-Giang-Huong N, Traisathit P, Cressey TR, Fregonese F, Leurent B, Collins IJ, Techapornroong M, Banchongkit S, Buranabanjasatean S, Halue G, Nilmanat A, Luekamlung N, Klinbuayaem V, Chutanunta A, Kantipong P, Bowonwatanuwong C, Lertkoonalak R, Leenasirimakul P, Tansuphasawasdikul S, Sang-A-Gad P, Pathipvanich P, Thongbuaban S, Wittayapraparat P, Eiamsirikit N, Buranawanitchakorn Y, Yutthakasemsunt N, Winiyakul N, Decker L, Barbier S, Koetsawang S, Sirirungsi W, McIntosh K, Thanprasertsuk S, Lallemant M; PHPT-3 study team.

PLoS Med. 2013 Aug;10(8):e1001494. doi: 10.1371/journal.pmed.1001494. Epub 2013 Aug 6.

Supplemental Content

Support Center